In clinical Acinetobacter species, the reduction effects of organic material on bactericidal activities of four major disinfectants were investigated: chlorhexidine gluconate (CHX), benzethonium chloride (BZT), benzalkonium chloride (BZK) and alkyl diaminoethyl glycine hydrochloride (ADH).
Introduction
Acinetobacter species have recently been recognized as one of the major hospital-acquired pathogens that cause opportunistic infections such as pneumonia, urinary tract infections, septicaemia and surgical site infections, particularly in immunocompromised patients 1,2 accommodated in intensive care units where they commonly undergo invasive medical procedures and tend to receive various broad-spectrum antimicrobial agents. 3, 4 Moreover, Acinetobacter species have rapidly developed multidrug resistance capabilities over the past 10 years, and the increasing difficulties encountered in the treatment of infections caused by this opportunistic pathogen have become a serious clinical concern. 5 -7 The ability of this microbe to survive longterm in hospital environments even on dry surfaces has also been considered to play a crucial role in hospital-acquired infection. 8, 9 Biocides, including quaternary ammonium compounds (QACs) and bisbiguanides, have been assiduously used in hospitals and healthcare facilities, and have significantly contributed to maintaining sanitary conditions and preventing hospital-acquired infections. 10 However, concerns have also been raised that widespread use of disinfectants could serve to select disinfectant-insusceptible microbes among hospital-acquired pathogens such as methicillinresistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. 11, 12 Evidence for the development of reduced susceptibility due to exposure to disinfectants has been reported. For example, a steady increase in MICs of chlorhexidine for P. aeruginosa has resulted from the exposure to residual disinfectants at subinhibitory concentrations. 13 It is possible that Acinetobacter species may also have developed insusceptibility to disinfectants because of their innate ability to survive long-term on body surfaces and in hospital environments in which various disinfectants have been consumed.
Another cause for concern is that organic materials are known to reduce the effectiveness of disinfectants and antiseptics. Because these agents have been extensively used in medical and healthcare facilities for the disinfection of mucous membranes and wounds, and for the sterilization of medical instruments and equipment surfaces, which often tend to be contaminated with organic materials, the influence of such materials should not be ignored from the viewpoint of practical use of disinfectants. Therefore, it is very important to understand the susceptibility status of Acinetobacter species against disinfectants, as well as the influences of organic materials upon reduction in their efficacies. Since little is known about the present susceptibility status of Acinetobacter species to disinfectants, the aim of this study was to assess the susceptibility profiles of clinically isolated Acinetobacter species, isolated in 2002. For the isolates with 'disinfectant reduced susceptibility (DRS)' selected from clinical isolates, the bactericidal activities of QACs, bisbiguanides and ampholytic detergents used widely in medical facilities were evaluated both with and without the organic materials. In addition, the adaptive resistance to four disinfectants was also investigated to predict the potential development of resistance to disinfectants in Acinetobacter species.
Materials and methods

Bacterial strains and culture media
In March 2002, 283 non-repetitive clinical isolates identified as Acinetobacter species were collected from 97 hospitals located in different geographical areas of Japan. Since these isolates were speculated to be major causative microbes of infection in each patient, they were subjected to identification and antibioticsusceptibility tests. They were identified as 273 Acinetobacter calcoaceticus-Acinetobacter baumannii complex, 7 Acinetobacter lwoffii and 3 Acinetobacter junii by their biochemical identification using the API20NE system (bioMérieux Japan, Ltd, Tokyo, Japan) and a complementary test for the ability to grow at 37, 41 and 448C. After re-identification, each isolate was grown on Luria-Bertani (LB) agar plates or in LB broth (Becton -Dickinson Diagnostic System, Sparks, MD, USA) for further studies.
Disinfectants and susceptibility testing
The disinfectants were obtained from the following sources: chlorhexidine gluconate (CHX), benzethonium chloride (BZT), Wako Pure Chemical Industries, Ltd, Osaka, Japan; benzalkonium chloride (BZK), Kanto Chemical Co., Inc., Tokyo, Japan; alkyl diaminoethyl glycine hydrochloride [ADH; TEGO 51TM, 10% (w/v) solution]. The MICs of the disinfectants were determined by the broth microdilution method using Mueller -Hinton broth (Becton -Dickinson Diagnostic System) according to the protocol recommended by the CLSI (formerly NCCLS) in document M100-S14. 14 
Assay of bactericidal activity: quantitative suspension test
The bactericidal effects of disinfectants on Acinetobacter species were measured using a slightly modified quantitative suspension test referring to the European Standard EN 1040. 15 The neutralizer solution used in the suspension test contained the following: 10% Tween 80 (v/v), 3% lecithin (w/v), 0.1% histidine (w/v), 0.5% sodium thiosulphate (w/v) and phosphate-buffered saline (PBS, pH 7.4), all obtained from Wako Pure Chemical Industries.
Each isolate was cultivated in LB broth until its optical density (OD) of 0.90 at 660 nm was reached and washed once with PBS ( pH 7.4). The bacterial test suspensions were then adjusted to an optical density of 0.08 at 660 nm ($10 8 cfu/mL), and bacterial test suspensions were prepared for each strain. A 100 mL of test suspension was added to tubes containing 900 mL of disinfectant solutions at different concentrations and left for 3 min at 20 + 28C. Since the test results obtained at room temperature demonstrated poor reproducibility, all reactions were performed as much as possible at 20 + 28C in an incubator using bacterial suspensions, disinfectant solutions and neutralizer solutions preincubated at 20 + 28C. Aliquots of the reaction mixture (100 mL) of containing bacterial cells and disinfectant were then added to 900 mL of neutralizer solution at 20 + 28C for 3 min and serially diluted in PBS ( pH 7.4). After dilution, 50 mL of the mixture was spread immediately onto LB agar plates and incubated for 18 h at 358C. The numbers of colonies surviving on each plate were counted, and cell survival rates were calculated with those obtained by a test using a bacterial suspension treated with PBS ( pH 7.4) instead of disinfectant as the control. BSA (Sigma) was used to imitate organic soiling, thus ensuring that the 'dirty' test simulated practical 'in-use' conditions. The quantitative suspension tests with BSA were performed according to recommendation EN 1276. 16 Each test was repeated to simulate 'dirty' conditions by mixing the test suspension with 0.3% or 3.0% (w/v) BSA solution before adding the 100 mL of test suspension to the 900 mL of disinfectant solution. The experiments were repeated three times on different days. In addition, the neutralizer was checked for its possible toxicity for the test organisms. Aliquots of a diluted bacterial suspension (100 mL) containing 1-3 Â 10 4 cfu/mL was added to 900 mL of neutralizer and left at 20 + 28C for 3 min. Two samples of 100 mL of mixture described above were then spread onto LB agar plates and incubated as above. The values obtained on each plate were 100-300 cfu/100 mL. Finally, the inactivation of the bactericidal activity of each disinfectant by neutralizer was also validated. Nine hundred microlitres of the solutions containing different concentrations of each disinfectant was added to 100 mL of the PBS ( pH 7.4) and left at 20 + 28C for 3 min. Then, 100 mL of the mixture was transferred into 800 mL of neutralizer and left at 20 + 28C for 3 min. Aliquot of a diluted bacterial suspension (100 mL) containing 1-3 Â 10 4 cfu/mL was then added and left at 20 + 28C for 3 min. Two samples of 100 mL mixture, containing disinfectant, neutralizer and bacteria, were then spread onto LB agar plates and incubated as described above. The numbers of colonies grown on each plate ranged from 100 to 300 cfu/100 mL.
MBC
MBC was determined using the quantitative suspension test described above. The disinfectant solutions at different concentrations were made by serial 2-fold dilutions of each disinfectant.
MBC was defined as the lowest concentration of disinfectants that completely suppressed bacterial growth in each disinfectant.
Measurement of bactericidal activity: time-killing assay
Time-killing assays were performed to evaluate the bactericidal effects of disinfectants using a modified quantitative suspension test referring to the European Standards EN1040 and EN1276. Bacterial cell suspension (100 mL) was added to 900 mL of disinfectant solution and 50 mL aliquots of the mixtures were sampled at 0.5, 1, 2.5, 5, 10, 20, 30, 60, 90 and 120 min, respectively. Each sample was immediately added to 450 mL of neutralizer solution at 20 + 28C and left for 3 min, then serially diluted in PBS ( pH 7.4). Fifty microlitres of each diluent was spread onto LB agar plate and incubated for 18 h at 358C. The numbers of colonies that grew on each plate were counted, and cell survival rates were calculated by similar methods using a bacterial suspension as the control treated with PBS ( pH 7.4) instead of the mixture containing disinfectant and neutralizer solution. The test was repeated to simulate 'dirty' conditions using the test suspension containing a 0.3% or 3.0% (w/v) BSA by the same method employed in the MBC measurement. The experiments were repeated three times on different days.
Adaptation to disinfectants
Twelve strains, including five disinfectant-susceptible clinical isolates and seven DRS isolates, strains 1, 2, 4, 5, 6, 7 and 10 shown in Table 2 , were subjected to the adaptation test. Five susceptible clinical isolates were randomly selected from the group of strains for which the MICs of all four disinfectants were less than MIC 50 as shown in Table 1 . Aliquots of the overnight culture (100 mL) were added to nutrient broth containing each agent at 1/2 of the MIC for each strain. The 1/2 MIC culture was incubated at 378C with shaking for 72 h, and bacterial growth was assessed visually. When a culture density of higher than $1 Â 10 8 cfu/mL was observed, 100 mL of the 1/2 MIC culture was spread onto nutrient agar plates containing the same concentration of disinfectant, and the agar plates were incubated overnight at 378C. The colonies grown on each agar plate were selected and cultured for further testing using nutrient broth containing 1/2 MIC disinfectant. An aliquot of cell culture was stored at 2808C as passage 1 (P1), and MICs and MBCs for P1 were re-determined. Any isolates that had shown an increase in MICs and MBCs were then inoculated into the broth media containing twice the original concentration of disinfectant, and the others not shown augmented MICs and MBCs were inoculated into media containing the disinfectant with the previous concentration. This procedure was repeated four times every 5 days (including 3 days for culture and 2 days for assay) after the selection of P1. If culture density was lower than 1 Â 10 8 cfu/mL, the passage was not advanced to the next step, because no .5 log 10 reduction could be detected in this condition. The stabilities of the MICs and MBCs for P5 isolates demonstrating highest disinfectant-reduced susceptible profile were checked four times every 5 days by repetitive culture with disinfectant-free broth. Moreover, the bactericidal activities of each disinfectant for these adapted isolates were evaluated by the quantitative suspension tests. The experiments were repeated three times on different days.
Statistical analysis
Data were analysed using the statistical program SPSS for Windows version 11.0J (SPSS Inc., Chicago, IL, USA). The Mann-Whitney U-test was performed to compare bactericidal activities measured by both MBC and time-killing assays. Dunnett's and Bonferroni's multiple comparison tests were performed to determine statistically significant differences between passage groups of the adaptation test. A P value of 0.05 was considered statistically significant.
Results
Susceptibility to disinfectants and selection of DRS isolates
Distributions of MICs of CHX, BZK, BZT and ADH for 283 clinical isolates are shown in Table 1 . Acinetobacter species tended to be susceptible to CHX, BZK and BZT, and MIC 90 s obtained by the broth microdilution method in the absence of BSA were 25 mg/L. However, MICs of ADH were relatively higher than those of the other three disinfectants, and the MIC 90 of ADH obtained was 100 mg/L ( Table 1) .
The isolates with DRS possessing relatively high MICs of CHX, BZK, BZT and/or ADH were selected. In the present study, the DRS isolates were defined as those for which MICs of at least two among the four disinfectants were higher than MIC 90 when measured by the broth microdilution method. As a result, 14 isolates (8 A. baumannii, 4 A. calcoaceticus and 2 A. junii) out of 283 were provisionally defined as DRS isolates in the present study ( Table 2) .
MBCs of four disinfectants
To evaluate the phenotypes of DRS isolates selected, the MBC and bactericidal activity of the four disinfectants were measured under both the so-called 'clean' and 'dirty' conditions. Figure 1 shows cell survival rates of DRS isolates after exposure to CHX, BZK, BZT and ADH, with concentrations ranging from 1 to 1024 mg/L. The MBC values of the four disinfectants in the presence of BSA were higher than those in the absence of BSA, and MBC values of BZK, BZT and ADH obtained by the addition of 3.0% BSA showed high values (512 and 1024 mg/L), which were about half of the in-use concentration of these agents (Figure 1 ).
Time-killing assay
Time-killing assays were also performed to evaluate the bactericidal effects of the four disinfectants on DRS isolates from the viewpoint of exposure duration. As can be seen in Figure 2 , at low concentrations (MIC 50 of each disinfectant obtained by the broth microdilution method), the bacterial cell count in the absence of BSA reached a 5 log 10 reduction after 10 min. On the other hand, the presence of 0.3% BSA simulating the 'dirty' condition elevated the cell survival rate, and, even after 120 min of exposure, reduction of bacterial cells was less than 1 log 10 under the test conditions employed for BZK, BZT and ADH. Indeed, higher concentrations of disinfectants were reasonably more effective, especially under 'clean' conditions (Table 3) . However, the bacterial cell numbers failed to show a 5 log 10 reduction after a 1 min of exposure to all four disinfectants at 1/5 of the in-use concentrations in the presence of 3.0% BSA. As for ADH, bacterial cells survived even after a 10 min of exposure to 1000 mg/L, a half of the in-use concentration, with 3.0% BSA (Table 3) .
Adaptation to disinfectants
Five susceptible isolates and 7 DRS isolates selected from 283 isolates were subjected to an adaptation test. The adaptation profiles of these isolates are shown in Figure 3 . For five susceptible strains, the MICs of BZK, BZT and ADH were not significantly elevated after repetitive passages through the broth media containing each disinfectant. These five susceptible isolates were most susceptible to CHX among the four disinfectants, but these isolates could adapt to only 2-fold higher concentrations of CHX after five passages. The MICs of BZK, BZT and ADH for DRS isolates were only slightly elevated (,2-fold) during five passages. However, MICs of CHX were significantly elevated $10-fold (up to 640 mg/L) after the repeated passages. Similar findings were observed in the elevation of MBC values throughout the experimental process of passage as were seen in MIC (data not shown). The stability of disinfectant-reduced susceptible profile among strains demonstrating the highest adaptation ability was checked by culturing for 20 days in disinfectant-free broth. In some cases, the MIC or MBC of CHX for the adapted strains decreased approximately to 50%; however, no case declined to the level of parent strains (data not shown). Time-killing assays by suspension test were also performed to evaluate the bactericidal effect of CHX on both DRS and adapted isolates obtained through each passage process (Table 4) . No considerable changes in the bactericidal activity of BZK, BZT and ADH for adapted isolates obtained after passage in CHX were observed (data not shown). On the other hand, an apparent elevation of the resistance level to CHX in the adapted isolates was observed by suspension test. As can be seen in Table 4 , the bacterial cell counts of both DRS and adapted isolates showed a 5 log 10 reduction after a 1 min of exposure to 5000 mg/L CHX, that is, its in-use concentration. However, in P4 and P5 strains adapted for disinfectants, a 5 log 10 reduction of bacterial cells failed after a 1 min of exposure to 1000 mg/L CHX, 1/5 of its in-use concentration (Table 4) .
Discussion
In healthcare settings, it has become more difficult to treat infections caused by Acinetobacter species because of their acquisition of consistent resistance to major groups of antimicrobial agents. 5 -7 Difficulties in the infection control practices as well as in chemotherapy of infectious diseases are due to the intrinsic capacities of Acinetobacter species for long-term survival in Table 2 ) were subjected to this test. The 1/2 MIC cultures were incubated at 378C with shaking for 72 h, and growth was assessed visually for cultures grown in media containing disinfectants. MICs were checked, and any isolates that showed an increase in MICs were then inoculated into media containing twice the original concentration. This procedure was repeated a total of five times every 5 days (including 3 days for culture and 2 days for assay). Stabilities of adaptive resistances of most resistant bacterial cells (P5) were determined by further passages through disinfectant-free broths and checked four times every 5 days. The experiments were performed three times on different days. White bars, five disinfectant-susceptible isolates selected; black bars, seven DRS isolates. Error bars represent standard deviations, and a significant difference is indicated by P , 0.05 (as determined by Dunnett's and Bonferroni's multiple-comparison tests). The bacterial cell concentration exposed to each disinfectant was 3.40 + 0.81 Â 10 7 cfu/mL. a Shown as log 10 reduction in bacterial cell number in both 'clean' (0% BSA) and 'dirty' (0.3% and 3% BSA) conditions; mean + SD. b Numbers indicate 'in-use' concentration (mg/L) of each disinfectant. c Disinfectants failed to provide a 5 log 10 reduction in live bacterial cell counts in the presence of BSA. hospital environments and transmission among patients. Therefore, performance of contact-precautions including handhygiene and disinfection is crucial to interrupt patient-to-patient transmission of this microbe. Indeed numerous studies have focused on the issues of Acinetobacter species resistant to antimicrobial agents, 17, 18 but only a few have so far explored the susceptibility profiles to antiseptics and disinfectants in this microbe. Thus, investigations on the susceptibility status of clinically isolated Acinetobacter species' susceptibility to antiseptics and disinfectants assessed by four different test methods, MIC measurements, MBC measurements by quantitative suspension tests, time-killing assays and adaptation tests, would provide instructive new insights into coping with Acinetobacter species in various healthcare settings.
In the present study, the MIC 90 s of the four disinfectants tested for 283 Acinetobacter species isolates were 100 mg/L, which is lower than the actual in-use concentration of each disinfectant. Moreover, the 14 DRS isolates selected were also confirmed to be susceptible to disinfectants by multiple tests, including MBC measurement, and time-killing assay, in the absence of organic materials. The results are consistent with those of Martró et al. 19 and Wisplinghoff et al. 20 who found no apparent development of resistance to disinfectants among clinically isolated Acinetobacter species. They assessed the susceptibility of A. baumannii to respective disinfectants and antiseptics by suspension test without adding organic materials. However, since Acinetobacter species inhabit hospital environments often contaminated with a variety of organic materials and colonize various body sites of patients, one must never fail to take into account the reduction effects of organic materials on antiseptics and disinfectants in practical use. Therefore, we further extended their studies to evaluate the properties of DRS isolates against antiseptics and disinfectants by MBC measurements and timekilling assays in the presence of BSA. The 10 min of exposures of DRS isolates to CHX at much lower than its in-use concentration in the presence of 3.0% BSA provided a 5 log 10 reduction in bacterial cell numbers, whereas 10 min of exposure of these isolates to 200 mg/L BZK or 400 mg/L BZT failed to produce a 5 log 10 reduction of bacterial cells in the presence of 3.0% of BSA. In addition, the 10 min of exposure to 1000 mg/L ADH, half of its in-use concentration, failed to eliminate the live bacterial cells in the presence of 3.0% BSA. This finding is crucial, because ADH is one of the most frequently used disinfectants for medical instruments and hospital environments.
Acinetobacter species usually cause hospital-acquired infections, including urinary-and respiratory-tract infections, and particularly ventilator-associated pneumonia, especially in debilitated individuals. 1, 2, 21 Indeed, no apparent resistance properties of these DRS isolates against disinfectants were observed from the viewpoints of MIC and MBC measurements in the absence of organic materials, but the results obtained by the suspension test in the presence of BSA suggested that these DRS isolates may well survive in conditions of contamination by organic materials such as blood and exudation. Thus, care should be taken in monitoring the susceptibility profile of Acinetobacter species against disinfectants, especially when this microbe is frequently or continuously isolated from clinical samples.
To our knowledge, no adaptive resistance to disinfectants in strains belonging to Acinetobacter species has been reported to date. Our results demonstrate that repeated exposure to subinhibitory concentrations of CHX gradually elevated its MIC (at most 10-fold, up to 640 mg/L) for the DRS isolates. Furthermore, P4 and P5 strains obtained after several passages in 1/2 MICs of CHX survived after a 1 min of exposure to 1000 mg/L CHX, 20% of its in-use concentration (0.5% ¼ 5000 mg/L), in suspension test. CHX has been demonstrated to have a persistent or residual effect after applications to skin 22 and mucous membranes. 23 Irizarry et al. 24 suggested that environmental residues of CHX and cetylpyridinium chloride might confer some selective advantage on MRSA, an organism that has also been known as relatively resistant to CHX on dry surfaces. A recent study by Thomas et al. 13 gives some experimental support to the idea that repetitive exposure to subinhibitory concentrations of CHX results in a stable increase in MICs of CHX for P. aeruginosa. Acinetobacter species have also become very common in hospital environments as well as MRSA and P. aeruginosa known as the major hospital-acquired pathogens. Our results suggest that the DRS isolates, which have been exposed to some extent to subinhibitory amounts of disinfectants remaining on environmental surfaces or even on the skin, would also develop the properties of adaptive resistance to CHX. It would therefore be necessary to carefully screen and select appropriate disinfectants based on a sufficient understanding of each for use in medical facilities.
In conclusion, no resistance to CHX, BZX, BZT and ADH was detected among clinically isolated Acinetobacter species by MIC measurements. However, the bactericidal effects of BZK, BZT and ADH, especially on the DRS isolates, were remarkably reduced in the presence of an organic material (3% BSA). Furthermore, the DRS isolates tended to adapt a higher concentration of CHX after repetitive passages in 1/2 MIC concentrations of CHX. To prevent hospital-acquired infections caused by this kind of microbe, the profile of susceptibility to disinfectants, as well as to antimicrobial agents, must be carefully monitored and checked among Acinetobacter species isolated from both clinical specimens and environments. Disinfectants are indispensable to perform appropriate infection control. Hence, this study highlights the need to ensure that these agents are being used appropriately in practice at the correct concentrations and for adequate contact times.
